KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Tax Provisions (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Tax Provisions data on record, last reported at $26.2 million in Q4 2025.

  • For Q4 2025, Tax Provisions fell 41.91% year-over-year to $26.2 million; the TTM value through Dec 2025 reached $216.9 million, up 42.6%, while the annual FY2025 figure was $216.9 million, 42.6% up from the prior year.
  • Tax Provisions reached $26.2 million in Q4 2025 per EW's latest filing, down from $56.1 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $70.3 million in Q1 2025 and bottomed at $5.7 million in Q4 2023.
  • Average Tax Provisions over 5 years is $45.6 million, with a median of $50.9 million recorded in 2021.
  • Peak YoY movement for Tax Provisions: plummeted 73.41% in 2022, then surged 691.23% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $41.0 million in 2021, then tumbled by 73.41% to $10.9 million in 2022, then plummeted by 47.71% to $5.7 million in 2023, then soared by 691.23% to $45.1 million in 2024, then plummeted by 41.91% to $26.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $26.2 million in Q4 2025, $56.1 million in Q3 2025, and $64.3 million in Q2 2025.